Search Result |
Top |
| Entry | Name | Description | Category | Pathway | Gene |
|---|---|---|---|---|---|
| H01605 | Myelofibrosis | ... mutation, the MPL mutation, in the gene of the receptor of the thrombopoietin. Recently, mutations in the CALR gene have been described in 86% of cases with primary MF that are negative for JAK2 or MPL mutations ... | Cancer |
MPL [HSA:4352] [KO:K05082] JAK2 [HSA:3717] [KO:K04447] CALR [HSA:811] [KO:K08057] SH2B3 [HSA:10019] [KO:K12459] |
|
| H01612 |
Essential thrombocythemia Essential thrombocytosis Thrombocythemia |
... kinase activity of JAK2, resulting in uncontrolled cellular growth in the hematopoietic compartment. Calreticulin (CALR) or myeloproliferative leukemia virus oncogene (MPL) mutations occur in approximately ... | Hematologic disease |
(THCYT1) THPO [HSA:7066] [KO:K06854] (THCYT1) SH2B3 [HSA:10019] [KO:K12459] (THCYT1) CALR [HSA:811] [KO:K08057] (THCYT2) MPL [HSA:4352] [KO:K05082] (THCYT3) JAK2 [HSA:3717] [KO:K04447] |
| [ KEGG | DISEASE | DRUG | MEDICUS ] |